Literature DB >> 15372308

Rho-modifying C3-like ADP-ribosyltransferases.

K Aktories1, C Wilde, M Vogelsgesang.   

Abstract

C3-like exoenzymes comprise a family of seven bacterial ADP-ribosyltransferases, which selectively modify RhoA, B, and C at asparagine-41. Crystal structures of C3 exoenzymes are available, allowing novel insights into the structure-function relationships of these exoenzymes. Because ADP-ribosylation specifically inhibits the biological functions of the low-molecular mass GTPases, C3 exoenzymes are established pharmacological tools to study the cellular functions of Rho GTPases. Recent studies, however, indicate that the functional consequences of C3-induced ADP-ribosylation are more complex than previously suggested. In the present review the basic properties of C3 exoenzymes are briefly summarized and new findings are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372308     DOI: 10.1007/s10254-004-0034-4

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  45 in total

Review 1.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

2.  Localization of the C3-Like ADP-ribosyltransferase from Staphylococcus aureus during bacterial invasion of mammalian cells.

Authors:  Gabriella Molinari; Manfred Rohde; Christian Wilde; Ingo Just; Klaus Aktories; Gursharan S Chhatwal
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Kctd13 deletion reduces synaptic transmission via increased RhoA.

Authors:  Christine Ochoa Escamilla; Irina Filonova; Angela K Walker; Zhong X Xuan; Roopashri Holehonnur; Felipe Espinosa; Shunan Liu; Summer B Thyme; Isabel A López-García; Dorian B Mendoza; Noriyoshi Usui; Jacob Ellegood; Amelia J Eisch; Genevieve Konopka; Jason P Lerch; Alexander F Schier; Haley E Speed; Craig M Powell
Journal:  Nature       Date:  2017-11-01       Impact factor: 49.962

4.  The Staphylococcus aureus epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia.

Authors:  Patrick Munro; Maxime Benchetrit; Marie-Anne Nahori; Caroline Stefani; René Clément; Jean-François Michiels; Luce Landraud; Olivier Dussurget; Emmanuel Lemichez
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

5.  Structure function analysis of an ADP-ribosyltransferase type III effector and its RNA-binding target in plant immunity.

Authors:  Byeong-ryool Jeong; Yan Lin; Anna Joe; Ming Guo; Christin Korneli; Huirong Yang; Ping Wang; Min Yu; Ronald L Cerny; Dorothee Staiger; James R Alfano; Yanhui Xu
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

6.  Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.

Authors:  Julie Ménétrey; Gilles Flatau; Patrice Boquet; André Ménez; Enrico A Stura
Journal:  Protein Sci       Date:  2008-03-27       Impact factor: 6.725

7.  Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.

Authors:  Xiangmin Peng; Zhigang Zhou; Jian Hu; David J Fink; Marina Mata
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

8.  Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.

Authors:  Akiyuki Toda; Toshiharu Tsurumura; Toru Yoshida; Yayoi Tsumori; Hideaki Tsuge
Journal:  J Biol Chem       Date:  2015-06-11       Impact factor: 5.157

9.  Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).

Authors:  Ming Yan Xu; Joanne Porte; Alan J Knox; Paul H Weinreb; Toby M Maher; Shelia M Violette; Robin J McAnulty; Dean Sheppard; Gisli Jenkins
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

10.  Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.

Authors:  K M Mair; M R MacLean; I Morecroft; Y Dempsie; T M Palmer
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.